4//SEC Filing
Struthers Richard Scott 4
Accession 0001628280-25-058056
CIK 0001658247other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:54 PM ET
Size
13.9 KB
Accession
0001628280-25-058056
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-18$9.28/sh+16,342$151,654→ 336,359 total - Exercise/Conversion
Common Stock
2025-12-18$15.29/sh+28,400$434,236→ 364,759 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−16,342→ 0 totalExercise: $9.28Exp: 2028-05-24→ Common Stock (16,342 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−28,400→ 259,058 totalExercise: $15.29Exp: 2031-02-26→ Common Stock (28,400 underlying)
Holdings
- 661,205(indirect: By Trust)
Common Stock
- 106,000(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
- [F2]1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001746298
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:54 PM ET
- Size
- 13.9 KB